Research indicates a surge in type 2 diabetes diagnoses among women under 40, highlighting a shift towards younger populations and raising concerns over lifestyle factors and missed diagnoses. Type 2 diabetes is increasingly being diagnosed in younger adults, with the…
Egypt’s growing diabetes prevalence is driving a push to expand local insulin manufacturing, aiming to reduce reliance on imports while meeting increasing demand in one of the world’s most affected countries. Egypt’s rising diabetes burden is putting sustained pressure on…
A low-sugar blackcurrant jam made with fructose showcases a delicate balance between rich, tart flavour and health-conscious sweetness, emphasising slow cooking to preserve colour and nutrition. This innovative approach appeals to those seeking both tradition and modern dietary considerations, especially…
Eli Lilly’s new once-daily weight management tablet, foundayo, gains UK approval, marking a significant step in the evolving market for oral GLP-1 therapies amid increasing investor interest and market competition. Eli Lilly has won British approval for Foundayo, a once-daily…
New research indicates that different formulations of GLP-1 receptor agonists may offer diverse benefits including blood sugar, blood pressure, and cholesterol improvements, paving the way for tailored treatments beyond obesity management. A new analysis suggests GLP-1 medicines may do more…
Egyptian MP Irene Said emphasises the importance of maintaining quality and patient access amid plans to expand domestic pharmaceutical manufacturing, highlighting concerns over treatment suitability and supply reliability. Egyptian lawmaker Irene Said has urged caution over plans to expand local…
A recent retrospective study suggests that SGLT2 inhibitors may be associated with a reduced risk of dementia in adults with type 2 diabetes and a history of traumatic brain injury, prompting calls for further research. A class of diabetes medicines…
A new study suggests that starting SGLT2 inhibitors for adults with type 2 diabetes and a history of traumatic brain injury may lower the risk of developing dementia, marking a potential shift in neuroprotective strategies in complex diabetes care. In…
A recent case highlights the silent progression of diabetic retinopathy and underscores the importance of regular eye screenings and blood sugar control to prevent irreversible vision loss. Diabetic retinopathy is one of diabetes’s quietest dangers: it can damage the retina…
Venezuela’s health watchdog issues alert against unauthorised Glyxon tablets falsely marketed for treating chronic metabolic diseases, amid a global surge in illegal and counterfeit medicines for diabetes and weight loss. Venezuela’s autonomous health watchdog has warned against what it described…
